Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23094764
Abstract: The therapeutic benefits of the current medications for patients with psychiatric disorders contrast with a great variety of adverse effects. The endocannabinoid system (ECS) components have gained high interest as potential new targets for treating… read more here.
Keywords: psychiatric disorders; endocannabinoid system; disorders molecular; alterations ecs ... See more keywords